Implantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of VT/fibrillation
- 1 June 1994
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (16) , 1211-1213
- https://doi.org/10.1016/0002-9149(94)90184-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery diseaseThe American Journal of Cardiology, 1994
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- Implantable defibrillator therapy: Does it really prolong life? How can we prove it?The American Journal of Cardiology, 1993
- Antiarrhythmic drugsCurrent Opinion in Cardiology, 1993
- Routine prophylactic lidocaine administration in acute myocardial infarction. An idea whose time is all but gone?Circulation, 1992
- Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: The need for randomized trialsThe American Journal of Cardiology, 1992
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 casesAmerican Heart Journal, 1989
- Effect of antiarrhythmic drugs on mortality after myocardial infarctionThe American Journal of Cardiology, 1983
- Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillatorAmerican Heart Journal, 1981